@article{ref1,
title="[About the use of ketamine in emergency psychiatric settings]",
journal="Revue Medicale Suisse",
year="2021",
author="Sergentanis, Ioannis and Vibert, Vincent and Costanza, Alessandra and de Néris, Mélanie and Besson, Marie and Kosel, Markus and Bondolfi, Guido and Ambrosetti, Julia",
volume="17",
number="725",
pages="303-306",
abstract="Ketamine and its S-enantiomer, esketamine, have shown to be promising molecules for use in psychiatry. Widely investigated for the treatment of drug-resistant depression, they could be used in emergency conditions, due to their rapid onset of action, in two main conditions : 1) psychomotor agitation, and 2) acute suicidal ideation and behavior (suicidal crisis). In particular, intranasal administration offers a non-invasive, safe and very easy to administer option. An effect begins a few hours to a day after intake and lasts for about a week. These molecules present an innovative option for the future and their specific use in psychiatric emergencies.<p /><p>Language: fr</p>",
language="fr",
issn="1660-9379",
doi="",
url="http://dx.doi.org/"
}